Chapter 46 - Peripheral nerves Flashcards
The PNS includes the following structures EXCEPT A. CN I B. CN II C. Dorsal root D. Ventral root E. A and B F C and D
E. A and B (p. 1310)
Toxic acts directly on the membranes of Schwann cells near the DRG and adjacent parts of motor and sensory nerves (the most vascular parts of the peripheral nerve) A. Diphtheria B. PAN C. Tabes dorsalis D. Doxorubicin toxicity E. Arsenic F. Vincristine toxicity
A. Diphtheria (p. 1312)
Occlusion of vasa nervorum results in multifocal nerve infarctions A. Diphtheria B. PAN C. Tabes dorsalis D. Doxorubicin toxicity E. Arsenic F. Vincristine toxicity
B. PAN (p. 1312)
Meningoradiculitis of the posterior roots, mainly lumbosacral segments A. Diphtheria B. PAN C. Tabes dorsalis D. Doxorubicin toxicity E. Arsenic F. Vincristine toxicity
C. Tabes dorsalis (p. 1312)
Protein synthesis of DRG is blocked with subsequent neuronal destruction A. Diphtheria B. PAN C. Tabes dorsalis D. Doxorubicin toxicity E. Arsenic F. Vincristine toxicity
D. Doxorubicin toxicity (p. 1312)
Combines with the axoplasm of the largest sensory and motor nerves via sulfhydryl bonds A. Diphtheria B. PAN C. Tabes dorsalis D. Doxorubicin toxicity E. Arsenic F. Vincristine toxicity
E. Arsenic (p. 1312)
Damages the microtubular transport system A. Diphtheria B. PAN C. Tabes dorsalis D. Doxorubicin toxicity E. Arsenic F. Vincristine toxicity
F. Vincristine toxicity (p. 1312)
Focal degeneration of the myelin sheath with sparing of the axon A. Segmental demyelination B. Wallerian degeneration C. Axonal degeneration D. All of the above
A. Segmental demyelination (p. 1312)
Dying forward A. Segmental demyelination B. Wallerian degeneration C. Axonal degeneration D. All of the above
B. Wallerian degeneration (p. 1313)
Dying back A. Segmental demyelination B. Wallerian degeneration C. Axonal degeneration D. All of the above
C. Axonal degeneration (p. 1313)
Weakness of dorsiflexion, eversion, and inversion of the foot* A. Plexopathy B. Radiculopathy C. Mononeuropathy D. Neuronopathy E. Mononeuropathy multiplex
B. Radiculopathy (p. 1319)
Weakness of ankle dorsiflexion, foot eversion, and foot inversion is likely due to* A. L5 radiculopathy B. S1 radiculopathy C. Lumbosacral plexopathy D. Sciatic nerve pathology E. Peroneal nerve injury
A. L5 radiculopathy (p. 1319)
Inversion is spared in a foot drop A. L5 radiculopathy B. S1 radiculopathy C. Lumbosacral plexopathy D. Sciatic nerve pathology E. Peroneal nerve injury
E. Peroneal nerve injury (p. 1319)
Most common cause of acute or subacute generalized paralysis in practice A. GBS B. Polio C. Syringomyelia D. TB of the spine
A. GBS (p. 1322)
Most frequent identifiable antecedent infection in GBS A. Mycoplasma B. HIV C. Campylobacter jejuni D. HSV E. TB
C. Campylobacter jejuni (p. 1322)
Essential lesion in GBS A. Increase in CSF protein B. Edema of the nerve roots C. Perivascular mononuclear inflammatory infiltration of the roots and nerves D. Absence of inflammatory infiltrates
C. Perivascular mononuclear inflammatory infiltration of the roots and nerves (p. 1322)
Earliest immunologic event in GBS
A. Complement deposition on the myelin surface
B. Production of antibodies against myelin
C. Antigen-antibody reaction
D. None of the above
A. Complement deposition on the myelin surface (p. 1322)
Earliest symptoms of GBS A. Paresthesias in the toes and fingers B. Symmetric weakness C. Cranial nerve involvement D. Pain in the muscles
A. Paresthesias in the toes and fingers (p. 1333)
Variant of GBS associated with anti-GM1* A. Pure sensory B. Pure motor C. Pandysautonomia D. Axonal (AMAN)
D. Axonal (AMAN) (p. 1323)
Variant of GBS associated with anti-GQ1b* A. Ophthalmoplegia B. Oculopharyngeal weakness C. Cervico-brachial-pharyngeal weakness D. Bilateral facial or abducens weakness
A. Ophthalmoplegia (p. 1324)
Variant of GBS associated with anti-GT1a A. Ophthalmoplegia B. Oculopharyngeal weakness C. Cervico-brachial-pharyngeal weakness D. Bilateral facial or abducens weakness
C. Cervico-brachial-pharyngeal weakness (p. 1325)